Skip to content

Value of contrast-enhanced ultrasound combined with elastography in evaluating cervical lymph node metastasis in papillary thyroid carcinoma

Value of contrast-enhanced ultrasound combined with elastography in evaluating cervical lymph node metastasis in papillary thyroid carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019339
Enrollment
Unknown
Registered
2018-11-06
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTC

Interventions

Gold Standard:Puncture biopsy pathology
and&#32
elastography

Sponsors

Shenzhen Nanshan District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. The patients were diagnosed as PTC by puncture biopsy and planned for operation; 2. The patients who took no anti-thyroid drugs before the operation; 3. The patients who received preoperative contrast-enhanced ultrasound and elastography examination, and the data were kept intact; 4. The patients were underwent total or subtotal resection and central lymph node dissection and partial patients was performed neck dissection.

Exclusion criteria

Exclusion criteria: Exclusion criteria: The patients with severe liver failure, renal failure, hematopoietic dysfunction or with other serious medical diseases.

Design outcomes

Primary

MeasureTime frame
Contrast;elastography;

Countries

China

Contacts

Public ContactJiang Wei

Shenzhen Nanshan District People's Hospital

jwszdr@126.com+86 13026628099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026